- ZETA beat Q4 EPS estimates by $0.05 and posted 25.4% YoY revenue growth to $394.64M.
- Stock trades at $15.81 — 36% below the consensus analyst price target of $29.
- Institutional ownership sits at 87.75%; at least one RIA increased its stake by 794.6% in Q4.
Net Margin: -2.42%
Zeta Global closed Q4 with $394.64 million in revenue, up 25.4% year-over-year. Adjusted EPS came in at $0.28 against a $0.23 consensus — a clean beat. On the surface, that is a growth-stage company doing what it is supposed to do.
Below the surface, the picture is messier. Net margin printed at -2.42%. The company is not generating bottom-line profit at scale, and that remains the central tension in the ZETA thesis. Revenue growth is real. Profitability is not.
The stock currently trades at $15.81. Its 52-week range runs from $10.69 to $24.90. ZETA has already shed roughly 36% from its annual high. The gap between where analysts think it should trade ($29 average price target, consensus “Moderate Buy”) and where it actually trades is not a rounding error — it is a structural disconnect the market has not resolved.
Institutional holders control 87.75% of ZETA’s float. That concentration is a double-edged data point. It signals conviction from sophisticated allocators — but it also means retail-level selling pressure is not the primary driver of the stock’s compression. When institutions own this much and the stock is still down roughly 36% from its high, the question is not whether retail is fleeing. It is whether institutional holders are quietly trimming.
Register Financial Advisors LLC increased its ZETA position by 794.6% during Q4, ending the period with 107,350 shares worth approximately $2.19 million. Several other smaller RIAs added incrementally in Q3. These are not large absolute positions — the dollar amounts are in the tens of thousands for most entrants. The accumulation pattern is consistent with opportunistic dip-buying, not high-conviction anchor investing.
The more meaningful signal is what the larger institutional holders — those with multi-million-share blocks — are doing at the margin. That data is not in front of us here, and it is the data that matters most for near-term price direction.
ZETA beat estimates and grew revenue at 25%-plus. None of that has moved the stock back toward analyst targets, which means either the targets are wrong or the market is pricing in a risk the sell-side is not fully reflecting. The negative net margin at this revenue scale is not a minor footnote. Until free cash flow conversion becomes consistent and visible, the $29 price target functions more as a ceiling than a destination. Institutional concentration at 87.75% compresses the float — any large holder decision to reduce changes the supply dynamic fast.
Watch the Q1 2026 earnings print for net margin trajectory — any improvement toward breakeven resets the profitability narrative and is the single most actionable catalyst for ZETA price target convergence.
Disclaimer: This post is for informational purposes only and does not constitute investment advice. All investment decisions and their outcomes are solely the responsibility of the reader.